https://www.selleckchem.com/pr....oducts/imlunestrant.
COVID-19 patients with ALT/AST elevations had a lower Ct value at admission (23 vs 25; .001), day 5 (24 vs 26; .001), and day 20 (31 vs 32; .001) after admission, compared with those without ALT/AST elevations. COVID-19 patients with ALT/AST elevations had a longer duration from first positive to first negative reverse transcription polymerase chain reaction test for SARS-CoV-2 (13 vs 9 days; .001). ALT/AST elevation and presence of diabetes were independent risk factors of viral persistence. Liver injury in COV
Like
Comment
Share
